Favorable intermediate risk prostate cancer with biopsy Gleason score of 6

被引：0
|
作者：
Jong Jin Oh
Hyungwoo Ahn
Sung Il Hwang
Hak Jong Lee
Gheeyoung Choe
Sangchul Lee
Hakmin Lee
Seok-Soo Byun
Sung Kyu Hong
机构：
[1] Seoul National University Bundang Hospital,Department of Urology
[2] Seoul National University College of Medicine,Department of Urology
[3] Seoul National University Bundang Hospital,Department of Radiology
[4] Seoul National University College of Medicine,Department of Radiology
[5] Seoul National University Bundang Hospital,Department of Pathology
来源：
BMC Urology | / 21卷
关键词：
Prostate cancer; Intermediate risk group; MRI;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
    Oh, Jong Jin
    Ahn, Hyungwoo
    Hwang, Sung Il
    Lee, Hak Jong
    Choe, Gheeyoung
    Lee, Sangchul
    Lee, Hakmin
    Byun, Seok-Soo
    Hong, Sung Kyu
    [J]. BMC UROLOGY, 2021, 21 (01)
  • [2] Redefining intermediate risk prostate cancer using Gleason score
    Pollard, M.
    Lavery, H. J.
    Hobbs, A. R.
    Hall, S.
    Levinson, A. W.
    Samadi, D. B.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E766 - U626
  • [3] Limitations of biopsy Gleason grade: Implications for counseling patients with biopsy Gleason score 6 prostate cancer
    Sved, PD
    Gomez, P
    Manoharan, M
    Kim, SS
    Soloway, MS
    [J]. JOURNAL OF UROLOGY, 2004, 172 (01): : 98 - 102
  • [4] Influence of Active Surveillance on Gleason Score Upgrade and Prognosis in Low- and Favorable Intermediate-Risk Prostate Cancer
    Hu, Xuanhan
    Miao, Jia
    Huang, Jiaqing
    Qian, Lin
    Zhang, Dahong
    Wei, Haibin
    [J]. CURRENT ONCOLOGY, 2022, 29 (10) : 7964 - 7978
  • [5] Comparison of Pathological and Oncologic Outcomes of Favorable Risk Gleason Score 3+4 and Low Risk Gleason Score 6 Prostate Cancer: Considerations for Active Surveillance
    Gearman, Derek J.
    Morlacco, Alessandro
    Cheville, John C.
    Rangel, Laureano J.
    Karnes, R. Jeffrey
    [J]. JOURNAL OF UROLOGY, 2018, 199 (05): : 1188 - 1195
  • [6] Multiparametric magnetic resonance imaging for prostate cancer improves Gleason score assessment in favorable risk prostate cancer
    Kamrava, Mitchell
    Kishan, Amar U.
    Margolis, Daniel J.
    Huang, Jiaoti
    Dorey, Fred
    Lieu, Patricia
    Kupelian, Patrick A.
    Marks, Leonard S.
    [J]. PRACTICAL RADIATION ONCOLOGY, 2015, 5 (06) : 411 - 416
  • [7] Re: Comparison of Pathological and Oncologic Outcomes of Favorable Risk Gleason Score 3+4 and Low Risk Gleason Score 6 Prostate Cancer: Considerations for Active Surveillance
    Iczkowski, Kenneth A.
    [J]. JOURNAL OF UROLOGY, 2018, 200 (04): : 905 - 905
  • [8] Patient risk stratification using Gleason score concordance and upgrading among men with prostate biopsy Gleason score 6 or 7
    Serkin, Faye B.
    Soderdahl, Douglas W.
    Cullen, Jennifer
    Chen, Yongmei
    Hernandez, Javier
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2010, 28 (03) : 302 - 307
  • [9] Advancing age and the risk of adverse pathology at radical prostatectomy in men with biopsy Gleason score 6 prostate cancer
    Kim, Daniel
    Chen, Ming-Hui
    Huland, Hartwig
    Graefen, Markus
    Tilki, Derya
    D'Amico, Anthony Victor
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [10] Influence of Biopsy Gleason Score on the Risk of Lymph Node Invasion in Patients With Intermediate-Risk Prostate Cancer Undergoing Radical Prostatectomy
    Wenzel, Mike
    Preisser, Felix
    Hoeh, Benedikt
    Welte, Maria N.
    Humke, Clara
    Wittler, Clarissa
    Wuernschimmel, Christoph
    Becker, Andreas
    Karakiewicz, Pierre I.
    Chun, Felix K. H.
    Mandel, Philipp
    Kluth, Luis A.
    [J]. FRONTIERS IN SURGERY, 2021, 8
12345